Dr. Dissanayake is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1545 Airport Blvd
Pensacola, FL 32504Phone+1 850-416-6933Fax+1 850-416-6934
Education & Training
- Cook County Health and Hospitals SystemFellowship, Hematology and Medical Oncology, 1998 - 2001
- Rush University Medical CenterResidency, Internal Medicine, 1995 - 1998
- University of Peradeniya FOMClass of 1991
Certifications & Licensure
- IL State Medical License 1995 - 2026
- FL State Medical License 2002 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsTherapeutic plasma exchange for massive anti-JK3-mediated hemolysis.Matthew D. Cain, Cheryl Roberts, Ranjith B. Dissanayake, Jill Adamski
Transfusion. 2013-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: